Suchergebnisse
Suchergebnisse:
ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Atrial Fibrillation. They should be essential in everyday clinical decision making.
- Guidelines Publication Schedule
ESC Guidelines and documents planned for 2024. Elevated...
- Guidelines Publication Schedule
30. Nov. 2023 · In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
2020ESC Guidelines for the diagnosisand management ofatrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart
- 7MB
- 126
- ESC Guidelines and Documents Planned For 2026
- ESC Guidelines and Documents Planned For 2025
- ESC Guidelines and Documents Planned For 2024
- ESC Guidelines and Documents Published in 2023
- ESC Guidelines and Documents Published in 2022
- ESC Guidelines and Documents Published in 2021
- ESC Guidelines and Documents Published in 2020
- ESC Guidelines and Documents Published in 2019
- ESC Guidelines and Documents Published in 2018
- ESC Guidelines and Documents Published in 2017
Heart Failure Chairpersons: Marianna Adamo and Lars KøberCardiac rehabilitation Chairpersons: Maria Bäck and Dominique HansenChronic kidney disease in cardiovascular disease Chairpersons: Kevin Damman and William Herrington5th Universal definition of myocardial infarctionCardiovascular disease during pregnancy (Guidelines) Chairpersons: Julie De Backer and Kristina Hermann HaugaaCardiovascular disease and mental health (Consensus Statement) Chairpersons: Hector Bueno and Christi DeatonMyocarditis and pericarditis (Guidelines) Chairpersons: Massimo Imazio and Jeanette Schulz-MengerValvular heart disease (Joint Guidelines with EACTS) Chairpersons: Fabien Praz and Michael A. BorgerElevated blood pressure and hypertension Chairpersons: John William McEvoy and Rhian TouyzAtrial fibrillation Chairpersons: Isabelle C. Van Gelder and Dipak KotechaChronic coronary syndromes Chairpersons: Felicita Andreotti and Christiaan VrintsPeripheral arterial and aortic diseases Chairpersons: Lucia Mazzolai and José Rodriguez PalomaresAcute coronary syndromes Chairpersons: Robert Byrne and Borja IbanezCardiomyopathies Chairpersons: Elena Arbelo and Juan Pablo KaskiCardiovascular disease and diabetes Chairpersons: Nikolaus Marx and Massimo FedericiEndocarditis Chairpersons: Victoria Delgado and Michael BorgerVentricular arrhythmias and sudden cardiac death Chairpersons: Katja Zeppenfeld and Jacob Tfelt-HansenCardiovascular assessment and management of patients undergoing non-cardiac surgery Chairpersons: Sigrun Halvorsen and Julinda MehilliCardio-oncology Chairpersons: Alexander Lyon and Teresa Lopez-FernandezPulmonary hypertension Chairpersons: Stephan Rosenkranz and Marion DelcroixCardiac pacing Chairpersons: Jens Cosedis Nielsen and Michael GliksonValvular heart disease Chairpersons: Alec Vahanian and Friedhelm BeyersdorfCVD prevention Chairpersons: Francois Mach and Frank VisserenHeart failure Chairpersons: Theresa McDonagh and Marco MetraNon-ST segment elevation acute coronary syndromes Chairpersons: Jean-Philippe Collet and Holger ThieleAtrial fibrillation Chairpersons: Tatiana Potpara and Gerhard HindricksAdult congenital heart disease (previously grown-up congenital heart disease) Chairpersons: Helmut Baumgartner and Julie De BackerSports cardiology and physical activity in patients with cardiovascular disease Chairpersons: Antonio Pelliccia and Sanjay SharmaDiabetes, pre-diabetes and cardiovascular disease Chairpersons: Francesco Consentino and Peter GrantAcute pulmonary embolism Chairpersons: Stavros Konstantinides and Guy MeyerSupraventricular tachycardia Chairpersons: Josep Brugada and Demosthenes KatritsisChronic coronary syndromes (previously Stable Coronary Artery Disease) Chairpersons: William Wijns and Juhani KnuutiSyncope Chairpersons: Michele Brignole and Angel MoyaFourth universal definition of MI and myocardial Injury Chairpersons: Kristian Thygesen, Joseph Alpert and Harvey WhiteMyocardial revascularization Chairpersons: Franz Joseph Neumann and Miguel Sousa UvaCVD during pregnancy Chairpersons: Vera Regitz-Zagrosek and Jolien Roos-HesselinkAMI-STEMI Chairpersons: Stefan James and Borja IbanezFocused update on dual anti-platelet therapy Chairperson: Marco ValgimigliPeripheral arterial disease Chairpersons: Victor Aboyans and Jean-Baptiste RiccoValvular heart disease Chairpersons: Helmut Baumgartner and Volkmar Falk30. Nov. 2023 · The guideline provides key perspectives on the diagnosis and management of AF, including risk stratification, anticoagulation, ablation, and device-detected AF. It also classifies AF into stages based on the presence or absence of modifiable and nonmodifiable risk factors.
2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC) | Oxford Academic.
30. Nov. 2023 · The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation” provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation.
